Headlines

Johnson & Johnson

Investors Watch List : Johnson & Johnson (NYSE:JNJ), VIVUS Inc. (NASDAQ:VVUS), SVB Financial Group (NASDAQ:SIVB), AT&T, Inc. (NYSE:T), Modine Manufacturing Company (NYSE:MOD)

Chris Lewis02 mins

Johnson & Johnson (NYSE:JNJ) said on Tuesday that it would pay $1.75 billion in cash for Alios BioPharma, a private biotechnology company that is working on treatments for viral diseases. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly performance is -3.03%. On last trading day company shares…

Read More

Active Watch List : Johnson & Johnson (NYSE:JNJ), Applied Materials, Inc. (NASDAQ:AMAT), PTC Therapeutics, Inc. (NASDAQ:PTCT), DIRECTV (NASDAQ:DTV), Phillips 66 Partners (NYSE:PSXP)

Chris Lewis02 mins

Johnson & Johnson (NYSE:JNJ) announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. The acquisition will include Alios BioPharma’s portfolio of potential therapeutics for viral infections including compound AL-8176, an orally administered antiviral therapy currently…

Read More
Home